Blog

Qkine Joins Organoid COMMONS to Advance Standardization and Scalability in Human-Relevant Models

Qkine will collaborate with fellow pioneers to establish the manufacturing standards and standardized frameworks necessary to accelerate the adoption of organoid technologies in drug discovery and clinical research.
Blog

Qkine to distribute Defined Bioscience’s fully defined, animal-free cell culture media supplements

Qkine now supplies Defined Bioscience’s animal-free cell culture supplements
Blog

Reflections on the FDA Modernization Act 3.0 and how Qkine can be an enabling supplier for human-relevant, 100% animal-free, reproducible NAM workflows

In case you missed it, the 16th of December 2025 was a significant day in the US Senate, passing the […]
News

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
Blog

BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the rapidly growing cytokines market

BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing
News

Qkine Limited and Akron Bio Announce Strategic Partnership

Collaboration to Deliver High-Quality Cytokines and Growth Factors to Enable the Advancement of Stem Cell-Based Therapeutics
Blog

‍Qkine and Interlab announce distribution partnership in Taiwan

‍Qkine and Interlab based in Taipei, Taiwan, partner to distribute Qkine high purity growth factors and cytokines, empowering research in Taiwan.
Press Release

Qkine launches cell therapy grade recombinant proteins to support next-generation therapies

At Qkine we have repeatedly highlighted the need for stricter process and quality control in the manufacture of high purity in recombinant growth factors to prevent cross contamination with related growth factors. Contamination with other bioactive proteins leads to lack of inter and intra-lab reproducibility, or perhaps most concerningly incorrect scientific conclusions.
News

Updated shipping charges and options – September 2025

From 1st September, Qkine will be introducing updated delivery options designed to give you more choice, flexibility and reward ongoing support.
News

Qkine and 3D Bio-Tissues collaborate to improve cell-care for pluripotent stem cell and cellular agriculture applications

This collaboration merges 3D Bio-Tissues novel macromolecular crowding technology with that of Qkine in complex protein manufacturing and engineering to allow testing and validation and improve culture performance and bioprocessing yields.
News

Introducing Quoll Biosciences – Qkine’s New Partner in Oceania

Qkine announce distribution partnership with Quoll Biosciences, to supply Qkine high quality growth factors to Australia, New Zealand and Oceania.
News

Qkine and WildBio collaborate to progress cultivated meat from wild game species

For the cultivated meat industry, the goal is to produce a quality raw material quickly and at a reduced cost. At WildBio, with help from Qkine, we are harnessing the power of cells from wild game species in South Africa.
Shopping Basket